|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of iBio (AMEX: IBIO) through any online brokerage.
There are no as such competitors for iBio.
The latest price target for iBio (AMEX: IBIO) was reported by JMP Securities on November 29, 2021. The analyst firm set a price target for 1.50 expecting IBIO to rise to within 12 months (a possible 111.27% upside). 3 analyst firms have reported ratings in the last year.
The stock price for iBio (AMEX: IBIO) is $0.71 last updated Today at 5:13:45 PM.
There are no upcoming dividends for iBio.
iBio’s $Q2 earnings are confirmed for after-market on February 15, 2022.
There is no upcoming split for iBio.
iBio is in the sector and industry. They are listed on the AMEX.